SE426069B - Forfarande for framstellning av ett kristallint cefalosporinderivat - Google Patents

Forfarande for framstellning av ett kristallint cefalosporinderivat

Info

Publication number
SE426069B
SE426069B SE7709745A SE7709745A SE426069B SE 426069 B SE426069 B SE 426069B SE 7709745 A SE7709745 A SE 7709745A SE 7709745 A SE7709745 A SE 7709745A SE 426069 B SE426069 B SE 426069B
Authority
SE
Sweden
Prior art keywords
crystalline
procedure
preparation
cephalosporine derivative
cephalosporine
Prior art date
Application number
SE7709745A
Other languages
English (en)
Other versions
SE7709745L (sv
Inventor
K Naito
K Tsukamura
H Sinbo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7709745L publication Critical patent/SE7709745L/sv
Publication of SE426069B publication Critical patent/SE426069B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7709745A 1976-08-31 1977-08-30 Forfarande for framstellning av ett kristallint cefalosporinderivat SE426069B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51104583A JPS603314B2 (ja) 1976-08-31 1976-08-31 セフアロスポリン誘導体およびその製造法

Publications (2)

Publication Number Publication Date
SE7709745L SE7709745L (sv) 1978-03-01
SE426069B true SE426069B (sv) 1982-12-06

Family

ID=14384446

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7709745A SE426069B (sv) 1976-08-31 1977-08-30 Forfarande for framstellning av ett kristallint cefalosporinderivat

Country Status (15)

Country Link
US (1) US4146710A (sv)
JP (1) JPS603314B2 (sv)
BE (1) BE858296A (sv)
BG (1) BG60439B2 (sv)
CA (1) CA1102310A (sv)
CH (1) CH630088A5 (sv)
DE (1) DE2738711C2 (sv)
DK (1) DK151340C (sv)
FR (1) FR2364922A1 (sv)
GB (1) GB1589841A (sv)
HK (1) HK27784A (sv)
MY (1) MY8500266A (sv)
NL (1) NL189355C (sv)
NO (1) NO154015C (sv)
SE (1) SE426069B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4189479A (en) * 1977-12-22 1980-02-19 Takeda Chemical Industries, Ltd. Cephalosporin esters
US4180658A (en) * 1978-02-24 1979-12-25 Bristol-Myers Company 7[-2-Alkoxyamino(acetamido)]cephalosporin derivatives
JPS5579393A (en) * 1978-12-11 1980-06-14 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
JPS58189186A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd セフアロスポリン誘導体
JPS63266177A (ja) * 1987-04-22 1988-11-02 Toyota Autom Loom Works Ltd 揺動斜板型圧縮機におけるコンロツドの連結方法
JPH06122630A (ja) * 1992-10-12 1994-05-06 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
CN103601737B (zh) * 2013-12-04 2016-02-03 哈药集团制药总厂 一种盐酸头孢替安的制备方法
CN104926835B (zh) * 2015-06-24 2017-10-03 山东罗欣药业集团股份有限公司 一种盐酸头孢替安化合物、其制备方法及其药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho

Also Published As

Publication number Publication date
CH630088A5 (de) 1982-05-28
BG60439B2 (bg) 1995-03-31
HK27784A (en) 1984-03-30
DK151340C (da) 1988-04-25
BE858296A (fr) 1978-02-28
DE2738711C2 (de) 1985-07-11
MY8500266A (en) 1985-12-31
DK385777A (da) 1978-03-01
FR2364922A1 (fr) 1978-04-14
NL189355B (nl) 1992-10-16
NO154015B (no) 1986-03-24
FR2364922B1 (sv) 1981-07-31
NL189355C (nl) 1993-03-16
DE2738711A1 (de) 1978-03-02
GB1589841A (en) 1981-05-20
SE7709745L (sv) 1978-03-01
NO154015C (no) 1986-07-02
NL7709614A (nl) 1978-03-02
CA1102310A (en) 1981-06-02
NO772960L (no) 1978-03-01
JPS603314B2 (ja) 1985-01-26
US4146710A (en) 1979-03-27
JPS5329913A (en) 1978-03-20
DK151340B (da) 1987-11-23

Similar Documents

Publication Publication Date Title
FI65861B (fi) Anordning foer genomfoering av ett radioimmunologiskt foerfarande
SE426136B (sv) Forfarande for framstellning av ett pulverformigt, fririnnande monoglyceridadditiv
SE448790B (sv) Forfarande for framstellning av ett dokument
NO772085L (no) Fremgangsm}te for fremstilling av antibakterielle forbindelser
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
JPS5287223A (en) Production of hapten compound derivative
SE426069B (sv) Forfarande for framstellning av ett kristallint cefalosporinderivat
SE434593B (sv) Forfarande for framstellning av ett kakaofettersettningsmedel varvid salfett renas
SE426780B (sv) Forfarande for framstellning av ett cefalexinpreparat
NO772431L (no) Fremgangsm}te ved fremstilling av nye cephalosporinderivater
SE432250B (sv) Forfarande for framstellning av ett kinazolinderivat
SE433081B (sv) Forfarande for framstellning av cefalosporinforeningar
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE431335B (sv) Forfarande for framstellning av ett basiskt substituerat xantinderivat
SE418312B (sv) Forfarande for framstellning av ett dubbelgolv
NO147186C (no) Fremgangsmaate for fremstilling av substituerte purinforbindelser
NO790994L (no) Fremgangsmaate for fremstilling av et soyasapogenolderivat
SE7701453L (sv) Forfarande for framstellning av ett grundemnesrikt mineralpreparat
SE7908629L (sv) Ett nytt forfarande for framstellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK528777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
NO793989L (no) Fremgangsmaate til fremstilling av et krystallinsk salt av et cefalosporinderivat
SE7802140L (sv) Forfarande for framstellning av ett 9-hydroxietoximetyl-guaninderivat
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE7605751L (sv) Forfarande for framstellning av en bensotiazinforening
SE7601836L (sv) Forfarande for framstellning av ett dimerkaptoeltyleterderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7709745-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7709745-9

Format of ref document f/p: F